| Literature DB >> 33181855 |
Alexandra Othenin-Girard1, Julien Regamey2, Frédéric Lamoth3, Alice Horisberger4, Emmanouil Glampedakis5, Jean-Benoit Epiney6, Thierry Kuntzer7, Laurence de Leval8, Maude Carballares9, Claire-Anne Hurni10, Marco Rusca10, Olivier Pantet11, Stefano Di Bernardo12, Mauro Oddo11, Denis Comte13, Lise Piquilloud11.
Abstract
A 22-year-old male with a typical history of pauci-symptomatic COVID-19 3 weeks earlier, confirmed by positive serology for SARS-CoV-2 (IgG), was admitted to the intensive care unit because of severe myocarditis with refractory cardiogenic shock that required extracorporeal life support. Due to a clinical presentation suggestive of Kawasaki-like disease with coronary aneurysm and severe systemic inflammation, intravenous immunoglobulins were administered in combination with tocilizumab. The initial clinical course was favourable with these treatments. However, the patient subsequently developed a severe mononeuritis multiplex leading to bilateral foot drop, which required intensive immunosuppressive therapy (corticosteroids, cyclophosphamide and rituximab). The clinical presentation meets the criteria for multisystem inflammatory syndrome associated with SARS-CoV-2, but includes very severe organ damages. Early recognition, a multidisciplinary approach and aggressive therapeutic intervention can lead to a favourable outcome.Entities:
Year: 2020 PMID: 33181855 DOI: 10.4414/smw.2020.20387
Source DB: PubMed Journal: Swiss Med Wkly ISSN: 0036-7672 Impact factor: 2.193